HRTX

Heron Therapeutics (HRTX)

About Heron Therapeutics (HRTX)

Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in Cary, NC.

Details

Daily high
$1.42
Daily low
$1.36
Price at open
--
52 Week High
$2.68
52 Week Low
$1.00
Market cap
253.0M
Dividend yield
0.00%
Volume
27
Avg. volume
2.2M
P/E ratio
-17.06

Heron Therapeutics News

Details

Daily high
$1.42
Daily low
$1.36
Price at open
--
52 Week High
$2.68
52 Week Low
$1.00
Market cap
253.0M
Dividend yield
0.00%
Volume
27
Avg. volume
2.2M
P/E ratio
-17.06